AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
19:23
Anthropic debuted on Nasdaq at $111.50 per share and became the most valuable company listed through a public offering
19:21
Police are investigating a teacher from Pitești over antisemitic statements and Holocaust denial
19:11
The Dutch Embassy in Kyiv was damaged following a Russian drone attack. No one was injured, and the damage is minor.
19:08
Hidroelectrica is preparing the approval of the construction of a floating photovoltaic panel system on the Olt River, an investment of 1.4 billion lei
19:01
TNB has terminated director Felix Alexa’s contract
See more news